Procter & Gamble Company (The) (NYSE:PG - Get Free Report) shares rose 1.6% on Friday following a stronger than expected earnings report. The stock traded as high as $152.42 and last traded at $148.1120. Approximately 13,491,503 shares traded hands during trading, an increase of 22% from the average daily volume of 11,059,146 shares. The stock had previously closed at $145.71.
The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. During the same period in the previous year, the company earned $1.54 earnings per share. The company's quarterly revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be issued a $1.0885 dividend. This is an increase from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Friday, April 24th. Procter & Gamble's dividend payout ratio is presently 62.67%.
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Q3 beat on both EPS and revenue, driven by volume‑led organic sales growth and strength in beauty (global beauty net sales up ~11%); results showed the first quarter of volume growth in a year, suggesting demand recovery. PG Announces Fiscal Year 2026 Third Quarter Results
- Positive Sentiment: Market reaction amplified by bullish flow — an unusual surge in call option buying the morning of the print, indicating short‑term trader optimism. (Trading data reported in market coverage.)
- Neutral Sentiment: Company reiterated fiscal 2026 guidance (EPS range 6.830–7.090) and revenue corridor, but noted EPS is likely toward the low end; maintenance of guidance reduces surprise risk but leaves upside limited versus consensus. Fiscal Q3 Core Earnings, Net Sales Increase; Outlook Maintained
- Negative Sentiment: Management flagged a ~$150 million hit to FY profit from higher energy/input costs tied to Middle East disruptions and supply‑chain energy impacts — a clear near‑term margin headwind that could pressure future EPS. Procter & Gamble Sees $150 Million Hit From From Middle East Disruptions, Maintains Outlook
- Negative Sentiment: Some analysts have trimmed price targets citing higher resin/energy costs and the risk to margins (BNP Paribas Exane, BofA adjustments), which may cap near‑term upside until costs normalize. BNP Paribas Adjusts Price Target on Procter & Gamble
Analysts Set New Price Targets
PG has been the topic of several research reports. TD Cowen decreased their price objective on shares of Procter & Gamble from $156.00 to $142.00 and set a "hold" rating on the stock in a report on Wednesday, April 1st. BNP Paribas Exane decreased their price objective on shares of Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating on the stock in a report on Thursday. Raymond James Financial reduced their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a research report on Tuesday, April 14th. Barclays reduced their target price on shares of Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 14th. Finally, Morgan Stanley decreased their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating on the stock in a research note on Wednesday. Twelve equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and an average price target of $162.37.
View Our Latest Report on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, insider Moses Victor Javier Aguilar sold 15,169 shares of the company's stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider owned 44,735 shares of the company's stock, valued at $7,259,595.80. This represents a 25.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Ma. Fatima Francisco sold 5,549 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $165.29, for a total transaction of $917,194.21. Following the completion of the transaction, the chief executive officer directly owned 1,029 shares of the company's stock, valued at $170,083.41. This trade represents a 84.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 252,715 shares of company stock valued at $40,966,904 over the last three months. 0.20% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in PG. Norges Bank bought a new position in shares of Procter & Gamble in the fourth quarter worth about $4,664,783,000. Cardano Risk Management B.V. lifted its holdings in shares of Procter & Gamble by 1,104.8% in the fourth quarter. Cardano Risk Management B.V. now owns 9,521,440 shares of the company's stock worth $1,364,518,000 after acquiring an additional 8,731,126 shares during the last quarter. Auto Owners Insurance Co increased its stake in shares of Procter & Gamble by 14,231.0% in the fourth quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company's stock valued at $508,700,000 after buying an additional 3,524,876 shares during the period. Vanguard Group Inc. increased its stake in shares of Procter & Gamble by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company's stock valued at $34,030,358,000 after buying an additional 2,829,151 shares during the period. Finally, Assenagon Asset Management S.A. boosted its position in Procter & Gamble by 100.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company's stock worth $782,607,000 after buying an additional 2,741,924 shares during the period. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Up 1.6%
The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The stock has a market capitalization of $344.21 billion, a P/E ratio of 21.94, a price-to-earnings-growth ratio of 5.50 and a beta of 0.41. The stock's fifty day simple moving average is $150.56 and its two-hundred day simple moving average is $148.72.
Procter & Gamble Company Profile
(
Get Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report